Avaliação do papel terapêutico do secretoma de células estromais mesenquimatosas em modelos genéticos da doença de Parkinson baseados na sobre-expressão de alfa-sinucleína
Year: 2021
Type: dissertation
Abstract: The presence of aggregates containing alpha-synuclein (a-syn) and selective loss of dopamine (DA) neurons in the substantia nigra pars compacta (SNpc) are the main characteristics of Parkinson’s Disease (PD). The secretome of mesenchymal stromal cells (MSCs) is the product of their secretory activity and is constituted by a panoply of vesicles, soluble proteins, lipids, and nucleic acids. These molecules, with broad and important roles, are essentially growth factors, anti-inflammatory and anti apoptotic factors, able to exert protective and regenerative actions in the brain tissue. Given the complexity of the mechanisms underlying PD pathophysiology and the richness of the secretome, its application in PD has been investigated, and different studies confirmed its therapeutic potential. Despite the weight of a-syn in the progression of PD, few studies have explored the effects of secretome in models that develop a-syn-mediated pathology. This thesis explored the effects of MSCs-derived secretome in Caenorhabditis elegans models that overexpress a-syn. We found that secretome not only reduced a-syn aggregation but also prevented the a-syn-induced DA neuron loss. Bioreactors are essential tools for large-scale production of secretome and they can alter MSCs secretion activity. We used two dynamic culture systems with distinct design to produce secretome. The capacity of the secretomes to induce neurodifferentiation and to protect DA neurons from the effects of a-syn was compared. The secretomes had different impacts in these models, which was consistent with their distinct protein profiles. Nevertheless, we concluded that the dynamic system, as well as other conditions may have contributed to these results. Finally, we attempted to establish in our laboratory an animal model (rat) of PD, based on the viral vector-mediated overexpression of a-syn, and test the secretome with the best outcomes in the previous study. We observed that animals displayed a significant loss of DA neurons of the SNpc and striatal DA terminals. Moreover, these animals had tendentially a lower motor performance. Secretome-treated animals presented an inferior DA neuron loss, reduced levels of a-syn in the SNpc, and a slightly higher motor performance. In summary, this work provided the basis for future studies using secretome in C. elegans models of PD. It provided new clues regarding the effects of different culturing protocols in the therapeutic potential of secretome and it also gathered more evidence regarding the neuroprotective capacity of the secretome from MSCs.
Author: Marques, Cláudia Raquel Ferreira
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1516346500, G1763632427, G2195151728, Modulation of the Mesenchymal Stem Cell Secretome using Vertical-Wheel Mixing Bioreactors, ICVS/3B’s - Laboratório Associado, Instituto de Ciências da Vida e da Saúde / Grupo de Investigação em Biomateriais, Biodegradaveis e Biomiméticos, ICVS/3B’s - Laboratório Associado, Instituto de Ciências da Vida e da Saúde / Grupo de Investigação em Biomateriais, Biodegradaveis e Biomiméticos, G3840324753, G5224927334, G862925997
OpenAlex ID: W7084256366
